Highlights • Sudden cardiac death is often caused by coronary artery disease among young adults. • Among young, sudden death is typically the first manifestation of the heart disease. •…
Little is known about the association between acute prevalent conditions in patients with type 2 Myocardial Infarction (T2MI) and clinical outcomes, particularly between genders. Using the Nationwide Inpatient Sample (2017),…
The Coronavirus disease 2019 (COVID-19) pandemic has changed the way patients seek medical attention and how medical services are provided. We sought to compare characteristics, clinical course, and outcomes of…
HIGHLIGHTS • Beta-blockers are often prescribed after-MI, but no specific one has been favored. • This study compares metoprolol versus carvedilol in an after-MI cohort. • The study showed similar…
Heart failure remains a major public health disease with high morbidity and mortality, and it is the leading cause of hospitalizations in older patients (>65 years). The role of sodium-glucose…
Renal transplant recipients are at higher risk for development of valvular heart disease, including mitral regurgitation. The management of severe mitral regurgitation among renal transplant recipients poses a challenging dilemma….
Every year, it is estimated that over 1 million cardiac catheterization procedures are performed in the United States. Traditionally, vascular access for cardiac catheterization procedures was obtained by femoral artery…
Peripheral artery disease (PAD) remains a major cause of morbidity and future cardiovascular events despite advancement in the surgical interventions and optimal medical therapy. The aim of our study is…
Highlights • A new integrated risk tool combines clinical and polygenic risk scores. • Prediction is significantly enhanced in multiple ethnicities and ancestries. • Ethnicities include Black and White, ancestries…
In the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis significantly reduced mortality and cardiovascular (CV)-related hospitalizations compared with placebo in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). This analysis aimed…
